Drug Discovery News: E. coli may hold the key to manufacturing hard-to-make drugs | Absci Drug Discovery News: E. coli may hold the key to manufacturing hard-to-make drugs - Absci

09.16.2021

Drug Discovery News: E. coli may hold the key to manufacturing hard-to-make drugs

Our founder and CEO, Sean McClain, spoke with Drug Discovery News about how Absci combines engineered E. coli with artificial intelligence to design effective, quality protein- and antibody-based drug candidates. Read more.